"Hemodialysis Solutions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (Na+, K+, Ca2+), and addition of carbohydrates (glucose).
| Descriptor ID |
D015312
|
| MeSH Number(s) |
D26.776.708.322.651 D27.505.954.578.483.651 D27.720.752.483.651
|
| Concept/Terms |
Hemodialysis Solutions- Hemodialysis Solutions
- Solutions, Hemodialysis
- Dialysis Solutions, Hemodialysis
- Hemodialysis Dialysis Solutions
- Solutions, Hemodialysis Dialysis
|
Below are MeSH descriptors whose meaning is more general than "Hemodialysis Solutions".
Below are MeSH descriptors whose meaning is more specific than "Hemodialysis Solutions".
This graph shows the total number of publications written about "Hemodialysis Solutions" by people in this website by year, and whether "Hemodialysis Solutions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemodialysis Solutions" by people in Profiles.
-
Effects of dialysate potassium concentration of 3.0?mmol/l with sodium zirconium cyclosilicate on?dialysis-free days versus dialysate potassium?concentration of 2.0 mmol/l alone on?rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025 Jan; 107(1):169-179.
-
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017 Feb; 69(2):266-277.
-
Novel antimicrobial catheter lock solution: a new direction in which chelators replace heparin. Crit Care Med. 2011 Apr; 39(4):875-6.
-
High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients. Nephrology (Carlton). 2010 Apr; 15(3):313-20.
-
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis. 2008 Mar; 51(3):362-5.
-
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9.
-
Changes in plasma free and phospholipid-bound choline concentrations in chronic hemodialysis patients. J Ren Nutr. 2000 Jul; 10(3):133-8.
-
Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999 Jan; 33(1):142-9.
-
Raising plasma phosphorus levels by phosphorus-enriched, bicarbonate-containing dialysate in hemodialysis patients. Artif Organs. 1992 Aug; 16(4):414-6.
-
Citrate for regional anticoagulation. Effects on blood PO2, ammonia, and aluminum. ASAIO Trans. 1988 Jul-Sep; 34(3):524-7.